08Nov/13

Pfizer Inc. : Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of … – 4-traders (press release)


Drug Discovery & Development

Pfizer Inc. : Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of
4-traders (press release)
Pfizer Inc. (NYSE:PFE) announced today top-line results from a Phase 3B/4 study of RAPAMUNE® (sirolimus) evaluating kidney transplant patients who transitioned from tacrolimus-based therapy (TAC) to RAPAMUNE® 3 to 5 months after transplant. The primary
Pfizer Inc. (NYSE:PFE) | Pfizer Announces Top-Line Results Of Phase 3B/4 Jutia Group
Pfizer says organ transplant drug fails in studyBusinessweek
Pfizer’s Rapamune Doesn’t Meet Primary Endpoint in Study of Kidney Transplant Wall Street Journal

all 4 news articles »

08Nov/13

Gum disease may lead to heart problems: Study – Times of India


Times of India

Gum disease may lead to heart problems: Study
Times of India
According to a study published in the Journal of the American Heart Association, researchers from Columbia University’s Mailman School of Public Health found an association between gum disease and progression of atherosclerosis, which is the hardening 
Healthy Teeth, Gums Mandatory to Ward off Heart ProblemsIBTimes India

all 6 news articles »